There are 1.6 million people diagnosed with cancer in the US each year. Of these, 650,000 receive chemotherapy. Did you know that 60,000 people a year are hospitalized for neutropenia, a common side effect of chemotherapy? One in fourteen die because of it. Of the 650,000 receiving chemotherapy, 104,000 are not aware of neutropenia and 52,000 don’t...
Read MoreIn a nutshell This study aimed to evaluate post-traumatic stress disorder (PTSD) in patients who have had treatment for cancer. This study found that a number of patients undergoing cancer treatment developed PTSD after treatment and recommended that supports are put in place. Some background Post-traumatic stress disorder (PTSD) is a...
Read MoreIn a nutshell This study aimed to evaluate post-traumatic stress disorder (PTSD) in patients who have had treatment for cancer. This study found that a number of patients undergoing cancer treatment developed PTSD after treatment and recommended that supports are put in place. Some background Post-traumatic stress disorder (PTSD) is a...
Read MoreIn a nutshell This study aimed to evaluate post-traumatic stress disorder (PTSD) in patients who have had treatment for cancer. This study found that a number of patients undergoing cancer treatment developed PTSD after treatment and recommended that supports are put in place. Some background Post-traumatic stress disorder (PTSD) is a...
Read More
After three hurricanes, flooding, fires and mudslides, and now severe cold and snow in the Deep South and throughout the country, the US has had its share of emergencies. Are you prepared? For people who rely on oxygen, who are on dialysis, have diabetes or other serious conditions, it is time to think about putting together some of the essentials. What...
Read More
In a nutshell This study aimed to find out if androgen deprivation therapy (ADT) is more effective used with docetaxel (Taxotere) or abiraterone (Zytiga). There was no significant difference found between the two treatment options. Some background Androgen deprivation therapy (ADT) is a treatment used for advanced prostate...
Read More
It has taken decades of work for researchers to find ways to activate the immune system to treat cancer (what we now call immuno-oncology or I-O). Much of that work has been poorly funded. Largely, it has been the result of researchers getting experience in other disciplines (like infectious disease) and then transferring that expertise to oncology...
Read More
In a nutshell This study investigated if the use of metformin for anti-diabetic therapy improved survival rates in men also treated for prostate cancer. They found that patients taking metformin may have a greater chance of survival from prostate cancer. Some background Metformin is a medication that is commonly used to lower blood sugar levels...
Read MoreIn a nutshell This study aimed to investigate treatments given after chemotherapy and hormonal therapy for metastatic prostate cancer, resistant to castration. This study found some benefit in abiraterone (Zytiga) or enzalutamide (Xtandi) but not in using docetaxel (Taxotere) again. Some background Androgen deprivation therapy...
Read MoreIn a nutshell This study aims to find out if local treatment with or without ADT is useful in the case of node-positive prostate cancer. This study found that local therapy and androgen deprivation therapy (ADT) is more effective for patients with node-positive prostate cancer than ADT alone. Some background Local treatment or...
Read More
“I think all too often we underestimate the impact of a cancer diagnosis on the mental health and well-being of the individual, thus it goes unaddressed.” ~Stephanie Zimmerman, MSN Receiving a diagnosis of cancer can bring on feelings of worry, fear, dread, anger, uncertainty and loss. Research indicates that, for some people, these symptoms of...
Read More
In a nutshell This study aimed to evaluate active surveillance as an option in intermediate stage prostate cancer. It found that it should be based on multiple criteria, but is still a viable option. Gleason score, PSA, volume of cancer in biopsy, age, and MRI results should all play a role in making the decision. Some background Active...
Read More
